DISCOVER INDIA

The Emerging Hub for Dental Health Investments

The Indian Opthalmic devices market is projected to grow from $420 million in 2022 to $820 million by 2030, registering a CAGR of 9% during the forecast period of 2022-2030.

Ophthalmology -Taevas

The glaucoma management devices market in India was valued at $140 million in 2022 and is projected to reach $250 million by 2030, registering a CAGR of 8.5% during the forecast period. 

The cataract surgery devices market in India was valued at $260 million in 2022 and is projected to reach $340 million by 2030, registering a CAGR of 7.5% during the forecast period.

Key Growth Drivers Fuelling Market ​

The prevalence of eye disorders is rising in India, due to several factors, including aging population, increasing pollution levels, and unhealthy lifestyle habits.

The disposable income of people in India is increasing, which is making them more willing to spend on healthcare. This is expected to boost the demand for expensive ophthalmology medical devices, such as intraocular lenses and phacoemulsification machines

The Indian government is increasingly focusing on preventive healthcare. This is leading to increased awareness about glaucoma and cataract disorders and the importance of early diagnosis and treatment.

NAVIGATING THE REGULATORY LANDSCAPE

Step-by-Step Registration Process

Product Registration

Ophthalmic medical devices in India are regulated under the Drugs and Cosmetics Act, 1940; and would require to be duly registered in India

Appoint an Authorized Indian Agent

Foreign ophthalmic medical device companies must appoint an Indian Authorized Agent with a wholesale license to act on their behalf.

Submit the Regulatory Dossier

A dossier under form 40 with required documents must be submitted. This includes:

  • Form 40 and TR6 Challan
  • Power of Attorney
  • ISO 13485 Certificate
  • Full Quality Assurance Certificate
  • CE Design Certificate
  • Free Sale Certificate
  • Other Regulatory Approvals
  • Plant Master File (PMF) and Device Master File (DMF)

Obtain Registration Certificate in Form 41

After document submission, the CDSCO will grant license or issue a query letter (if needed). The registration certificate is valid for 3 years

Obtain Import License in Form 10

The IAR should directly apply for import license using Form 10 in the CDSCO portal. This process would take 4 to 12 weeks.

Marketing in India

Once the process is completed the products can successfully market and sell in India. The IAR must ensure compliance with reporting changes, adverse events, recalls, to the CDSCO, if any.

Our Services

Empowering your Success in the Indian Market ​

Taevas is at the forefront of this expansion, supporting businesses as they navigate and conquer new markets. Our comprehensive range of services for the life sciences include

Market access solutions
Embarking on Success with Taevas

Embarking on Success with Taevas

Taevas stands ready to serve as your custom-fit partner in India, catering to your unique business requirements.

As Your Market Entry Partner
  • As your Indian Authorized Representative (IAR), we ensure your regulatory compliance
  • We identify potential distributors for your products and facilitate initial connections
  • You will lead the further development of these distributor relationships
As Your Commercial Partner
  • Along with being your IAR, we also act as your centralized distributor in India
  • We identify and appoint local distributors in different regions of India, creating a wide and efficient distribution network
  • You can focus on your core business, while we handle the complexities of distribution
As Your Operational Partner
  • Along with being your IAR, we also initiate the building of your local presence in India
  • We put together a dedicated team who takes charge of sales partnerships and manages the nuances of business operations
  • We ‘Build’ the infrastructure and set up processes; we ‘Operate’ the business, and when you feel ready, we ‘Transfer’ the control to you